|
Illumina Launches the VeriSeq NIPT Solution in Europe
Illumina, Inc. announced the launch of the VeriSeq NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked library prep and analysis software...
|
|
FDA approves two of Gilead hepatitis C drugs for pediatric patients
Gilead Sciences, Inc announced that the U.S. FDA has approved supplemental indications for Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg) tablets and Sovaldi (sofosbuvir 400 mg) tablets for the treatment of chronic hepatitis C virus (HCV) infection...
|
|